Latest From Biotech Now

Innovation Is… with Stephan Tanda, Managing Board Member, Royal DSM

ST-115x76

The term “innovation” is thrown around more often than Peyton Manning’s name during Fantasy Football season. But if any industry can truly capture the essence of innovation, it is the biotech industry. Innovation is inherent in what we do – from curing or treating illnesses that were once considered a death sentence to feeding a growing population to helping to reduce our dependence on foreign oil through the production of biofuels. But what is innovation, Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Prominent Washington State Newspapers Urge NO on Initiative 522

No-on-522-2 copy

The Seattle Times, The Columbian, The News Tribune and The Daily Herald are just a few of Washington state’s leading publications urging voters to check no on the upcoming state ballot Initiative 522, requiring labeling of genetically modified foods (GMOs), seeds and seed products sold in Washington. With the voting on ballot Initiative 522 nearing a close, the Vote No on 522 site did a wonderful job of compiling top quotes of notable Washington state Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , ,

BIO Announces Plenary Sessions for thePacific Rim Summit

Pac_Rim115x75

J. Craig Venter to deliver keynote: “Life at the Speed of Light” Biotechnology innovations and commercialization of renewable chemicals will be featured topics of plenary sessions at the 2013 Pacific Rim Summit on Industrial Biotechnology and Bioenergy. In a recent press release, the Biotechnology Industry Organization highlighted panelists and speakers presenting at this year’s plenary sessions, including its keynote speaker, J. Craig Venter, Founder, Chairman, and CEO, J.Craig Venter Institute; Founder and CEO to Synthetic Read More >

Environmental & Industrial  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Lots of Buzz at the BIO Investor Forum

Event

Thirty-eight biotech IPO’s this year. The NASDAQ Biotechnology Index is up 50 percent YTD.  Are we in a boom or a bubble? At the 12th Annual BIO Investor Forum,  that was the question on everybody’s mind. Nearly 600 biotech industry leaders, investors, and reporters gathered in San Francisco to find business partners, make connections, and hear our panelists discuss everything from Crowdfunding, the GAIN Act, the JOBS Act, and, of course, the booming IPO markets. Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

South Africa National Policy on Intellectual Property: Inconsistent with Biotech Development Goals

South-African-Flag

BIO submitted comments this week to the government of South Africa on their proposed “Draft National Policy on Intellectual Property.”  Below are some highlights. “BIO and its member companies are aware of the South African government’s aspirations to develop its life sciences industry, a message that South African officials communicated clearly at the recent BIO International Conference in Chicago, USA, in April 2013. At that conference and in subsequent discussions, South African officials have sent Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,